Innovation director appointed to NHS England
October 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NHS England, tony young
NHS England has hired a new national clinical director for innovation in Professor Tony Young. Young’s role will be to …
UK government and partners pay £230m for disease research
October 23, 2014Research and Development, Sales and Marketing Arthritis Research UK, British Heart Foundation, Cancer Research UK, London, MRC, Osborne, UK, Wellcome Trust, dementia, research
A new partnership led by the Medical Research Council and the UK government will invest over £230 million in a …
GSK mulls $27 billion ViiV sell-off
October 23, 2014Medical Communications, Sales and Marketing AIDS, Advair, GSK, HIV, Pfizer, Q3, Shionogi, Tivicay, ViiV
After a difficult few years and another poor quarter, GlaxoSmithKline has announced that it is looking to float its fast-growing …
J&J appoints head of marketing in northern Europe
October 23, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Johnson and Johnson, yana Ignatova
Johnson & Johnson has appointed Yana Ignatova to the position of head of marketing for its northern Europe division. Reporting …
J&J announces ‘major commitment’ to Ebola effort
October 22, 2014Sales and Marketing Crucell, Ebola, J&J, JJ, Vaccine, bavarian, johnson, niaid
Johnson & Johnson will invest $200 million to accelerate and significantly expand the production of its Ebola vaccine programme. The …
Boehringer seeks more indications for IPF drug
October 22, 2014Research and Development, Sales and Marketing Boehringer, IPF, NSCLC, colectoral, crc, nintedanib, ofev
Boehringer Ingelheim’s nintedanib has entered Phase III studies for the treatment of colorectal cancer (CRC), which could add to the …
NICE under increased pressure over conflicts of interest
October 22, 2014Sales and Marketing GPs, NHS, NICE, UK, baker, conflict, mccoll, wollaston
A group of influential doctors is calling on the government to tighten up NICE’s conflicts of interests policy. In a …
Epic Sciences hires chief information officer
October 22, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Michael Giske, epic sciences
San Diego-based diagnostics development firm Epic Sciences has appointed Michael Giske as its chief information officer. Giske has more than …
Shire interim chief financial officer resigns
October 21, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Shire, james bowling, merger
Shire’s interim chief financial officer James Bowling has left the firm for water company Severn Trent following the collapse of …
Parkinson’s UK appoints research director
October 21, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Arthur Roach, Parkinson's UK
Charity organisation Parkinson’s UK has appointed a leading pharma industry expert in Dr Arthur Roach as its research director. Roach …
AbbVie ditches Shire as tax deal falters
October 21, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Obama, Shire, US government, tax, tax inversion
Tax rule changes coming from the US government have forced the collapse of a multi-billion dollar deal between Humira manufacturer …
Medicine Innovation Bill a step closer in UK
October 20, 2014Sales and Marketing BBC, DH, NHS, innovation bill, saatchi
A new bill proposed by Conservative peer Lord Saatchi has been given government backing as it seeks to become law …
Admedus appoints two board directors
October 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing John Seaberg, Wayne Paterson, admedus
Australian-based healthcare product development firm Admedus has appointed two new directors to its board. John Seaberg and Wayne Paterson (pictured) …
Pharmacists could save the NHS £1.1 billion
October 20, 2014Sales and Marketing GP, GPs, NHS, UK, pharmacists
New research from the Royal Pharmaceutical Society shows that common ailments such as coughs and sore throats cost the NHS …
Working Life: MedImmune’s Dr Bing Yao
October 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MedImmune, Working Life, bing yao
How did you find your way into your current role? When I was pursuing my doctorate in microbiology and immunology, …
GSK: Ebola vaccines will come ‘too late’
October 17, 2014Manufacturing and Production, Research and Development, Sales and Marketing Ebola, GSK, JK-05, Sihuan, tekmira, vaccines, zmapp
GlaxoSmithKline says its potential Ebola vaccine will come ‘too late’ for the current outbreak despite being fast-tracked. In August the …
Roche and Pharmacyclics agree leukaemia pact
October 17, 2014Research and Development, Sales and Marketing BMS, CLL, Cancer, Gazyva, Pharmacyclics, Roche, imbruvica, leukaemia
Pharmacyclics’s cancer drug Imbruvica will be tested in combination with Roche’s Gazyva in a new partnership announced by the firms. …
Woodley commemorates 25 years in the industry
October 17, 2014Manufacturing and Production, Sales and Marketing Manchester, Supply, development, manufacturing, wickham, woodley
Medical supplier firm Woodley celebrated its 25-year anniversary this month at a lavish event at The Runway Visitor Park in …
Mobile telehealth to create ‘doctor in your pocket’ convenience
October 17, 2014Medical Communications, Sales and Marketing frost and sullivan, health, telehealth, videoconferencing, wearables
The telehealth industry is on the verge of a dramatic growth surge that is significantly disrupting the healthcare sector in …
Novartis cancer drug beating path to NHS
October 17, 2014Sales and Marketing GIST, Glivec, NHS, NICE, imatinib, uturn
NICE has issued final draft guidance recommending Novartis’s Glivec for up to three years in people who have had a …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
